<!DOCTYPE html>

<html xmlns="http://www.w3.org/1999/xhtml">

<head>

<meta charset="utf-8" />
<meta http-equiv="Content-Type" content="text/html; charset=utf-8" />
<meta name="generator" content="pandoc" />
<meta http-equiv="X-UA-Compatible" content="IE=EDGE" />

<meta name="viewport" content="width=device-width, initial-scale=1">

<meta name="author" content="Andrew Bean, Sebastian Weber" />

<meta name="date" content="2019-12-12" />

<title>Guiding Oncology Dose-Escalation Trials</title>



<style type="text/css">code{white-space: pre;}</style>
<style type="text/css" data-origin="pandoc">
a.sourceLine { display: inline-block; line-height: 1.25; }
a.sourceLine { pointer-events: none; color: inherit; text-decoration: inherit; }
a.sourceLine:empty { height: 1.2em; }
.sourceCode { overflow: visible; }
code.sourceCode { white-space: pre; position: relative; }
div.sourceCode { margin: 1em 0; }
pre.sourceCode { margin: 0; }
@media screen {
div.sourceCode { overflow: auto; }
}
@media print {
code.sourceCode { white-space: pre-wrap; }
a.sourceLine { text-indent: -1em; padding-left: 1em; }
}
pre.numberSource a.sourceLine
  { position: relative; left: -4em; }
pre.numberSource a.sourceLine::before
  { content: attr(title);
    position: relative; left: -1em; text-align: right; vertical-align: baseline;
    border: none; pointer-events: all; display: inline-block;
    -webkit-touch-callout: none; -webkit-user-select: none;
    -khtml-user-select: none; -moz-user-select: none;
    -ms-user-select: none; user-select: none;
    padding: 0 4px; width: 4em;
    color: #aaaaaa;
  }
pre.numberSource { margin-left: 3em; border-left: 1px solid #aaaaaa;  padding-left: 4px; }
div.sourceCode
  {  }
@media screen {
a.sourceLine::before { text-decoration: underline; }
}
code span.al { color: #ff0000; font-weight: bold; } /* Alert */
code span.an { color: #60a0b0; font-weight: bold; font-style: italic; } /* Annotation */
code span.at { color: #7d9029; } /* Attribute */
code span.bn { color: #40a070; } /* BaseN */
code span.bu { } /* BuiltIn */
code span.cf { color: #007020; font-weight: bold; } /* ControlFlow */
code span.ch { color: #4070a0; } /* Char */
code span.cn { color: #880000; } /* Constant */
code span.co { color: #60a0b0; font-style: italic; } /* Comment */
code span.cv { color: #60a0b0; font-weight: bold; font-style: italic; } /* CommentVar */
code span.do { color: #ba2121; font-style: italic; } /* Documentation */
code span.dt { color: #902000; } /* DataType */
code span.dv { color: #40a070; } /* DecVal */
code span.er { color: #ff0000; font-weight: bold; } /* Error */
code span.ex { } /* Extension */
code span.fl { color: #40a070; } /* Float */
code span.fu { color: #06287e; } /* Function */
code span.im { } /* Import */
code span.in { color: #60a0b0; font-weight: bold; font-style: italic; } /* Information */
code span.kw { color: #007020; font-weight: bold; } /* Keyword */
code span.op { color: #666666; } /* Operator */
code span.ot { color: #007020; } /* Other */
code span.pp { color: #bc7a00; } /* Preprocessor */
code span.sc { color: #4070a0; } /* SpecialChar */
code span.ss { color: #bb6688; } /* SpecialString */
code span.st { color: #4070a0; } /* String */
code span.va { color: #19177c; } /* Variable */
code span.vs { color: #4070a0; } /* VerbatimString */
code span.wa { color: #60a0b0; font-weight: bold; font-style: italic; } /* Warning */

</style>
<script>
// apply pandoc div.sourceCode style to pre.sourceCode instead
(function() {
  var sheets = document.styleSheets;
  for (var i = 0; i < sheets.length; i++) {
    if (sheets[i].ownerNode.dataset["origin"] !== "pandoc") continue;
    try { var rules = sheets[i].cssRules; } catch (e) { continue; }
    for (var j = 0; j < rules.length; j++) {
      var rule = rules[j];
      // check if there is a div.sourceCode rule
      if (rule.type !== rule.STYLE_RULE || rule.selectorText !== "div.sourceCode") continue;
      var style = rule.style.cssText;
      // check if color or background-color is set
      if (rule.style.color === '' && rule.style.backgroundColor === '') continue;
      // replace div.sourceCode by a pre.sourceCode rule
      sheets[i].deleteRule(j);
      sheets[i].insertRule('pre.sourceCode{' + style + '}', j);
    }
  }
})();
</script>



<style type="text/css">body {
background-color: #fff;
margin: 1em auto;
max-width: 700px;
overflow: visible;
padding-left: 2em;
padding-right: 2em;
font-family: "Open Sans", "Helvetica Neue", Helvetica, Arial, sans-serif;
font-size: 14px;
line-height: 1.35;
}
#header {
text-align: center;
}
#TOC {
clear: both;
margin: 0 0 10px 10px;
padding: 4px;
width: 400px;
border: 1px solid #CCCCCC;
border-radius: 5px;
background-color: #f6f6f6;
font-size: 13px;
line-height: 1.3;
}
#TOC .toctitle {
font-weight: bold;
font-size: 15px;
margin-left: 5px;
}
#TOC ul {
padding-left: 40px;
margin-left: -1.5em;
margin-top: 5px;
margin-bottom: 5px;
}
#TOC ul ul {
margin-left: -2em;
}
#TOC li {
line-height: 16px;
}
table {
margin: 1em auto;
border-width: 1px;
border-color: #DDDDDD;
border-style: outset;
border-collapse: collapse;
}
table th {
border-width: 2px;
padding: 5px;
border-style: inset;
}
table td {
border-width: 1px;
border-style: inset;
line-height: 18px;
padding: 5px 5px;
}
table, table th, table td {
border-left-style: none;
border-right-style: none;
}
table thead, table tr.even {
background-color: #f7f7f7;
}
p {
margin: 0.5em 0;
}
blockquote {
background-color: #f6f6f6;
padding: 0.25em 0.75em;
}
hr {
border-style: solid;
border: none;
border-top: 1px solid #777;
margin: 28px 0;
}
dl {
margin-left: 0;
}
dl dd {
margin-bottom: 13px;
margin-left: 13px;
}
dl dt {
font-weight: bold;
}
ul {
margin-top: 0;
}
ul li {
list-style: circle outside;
}
ul ul {
margin-bottom: 0;
}
pre, code {
background-color: #f7f7f7;
border-radius: 3px;
color: #333;
white-space: pre-wrap; 
}
pre {
border-radius: 3px;
margin: 5px 0px 10px 0px;
padding: 10px;
}
pre:not([class]) {
background-color: #f7f7f7;
}
code {
font-family: Consolas, Monaco, 'Courier New', monospace;
font-size: 85%;
}
p > code, li > code {
padding: 2px 0px;
}
div.figure {
text-align: center;
}
img {
background-color: #FFFFFF;
padding: 2px;
border: 1px solid #DDDDDD;
border-radius: 3px;
border: 1px solid #CCCCCC;
margin: 0 5px;
}
h1 {
margin-top: 0;
font-size: 35px;
line-height: 40px;
}
h2 {
border-bottom: 4px solid #f7f7f7;
padding-top: 10px;
padding-bottom: 2px;
font-size: 145%;
}
h3 {
border-bottom: 2px solid #f7f7f7;
padding-top: 10px;
font-size: 120%;
}
h4 {
border-bottom: 1px solid #f7f7f7;
margin-left: 8px;
font-size: 105%;
}
h5, h6 {
border-bottom: 1px solid #ccc;
font-size: 105%;
}
a {
color: #0033dd;
text-decoration: none;
}
a:hover {
color: #6666ff; }
a:visited {
color: #800080; }
a:visited:hover {
color: #BB00BB; }
a[href^="http:"] {
text-decoration: underline; }
a[href^="https:"] {
text-decoration: underline; }

code > span.kw { color: #555; font-weight: bold; } 
code > span.dt { color: #902000; } 
code > span.dv { color: #40a070; } 
code > span.bn { color: #d14; } 
code > span.fl { color: #d14; } 
code > span.ch { color: #d14; } 
code > span.st { color: #d14; } 
code > span.co { color: #888888; font-style: italic; } 
code > span.ot { color: #007020; } 
code > span.al { color: #ff0000; font-weight: bold; } 
code > span.fu { color: #900; font-weight: bold; }  code > span.er { color: #a61717; background-color: #e3d2d2; } 
</style>




</head>

<body>




<h1 class="title toc-ignore">Guiding Oncology Dose-Escalation Trials</h1>
<h4 class="author">Andrew Bean, Sebastian Weber</h4>
<h4 class="date">2019-12-12</h4>



<!--
%\VignetteEngine{knitr::rmarkdown}
%\VignetteIndexEntry{Guiding Oncology Dose-Escalation Trials}
-->
<div id="introduction" class="section level2">
<h2>Introduction</h2>
<p>The <code>OncoBayes2</code> package provides flexible functions for Bayesian meta-analytic modeling of the incidence of Dose Limiting Toxicities (DLTs) by dose level, under treatment regimes involving any number of combination partners. Such models may be used to support dose-escalation decisions and estimation of the Maximum Tolerated Dose (MTD) in adaptive Bayesian dose-escalation designs.</p>
<p>The package supports incorporation of historical data through a Meta-Analytic-Combined (MAC) framework [1], which stratifies these heterogeneous sources of information through a hierarchical model. Additionally, it allows the use of EXchangeable/Non-EXchangeable (EX/NEX) priors to manage the amount of information-sharing across subgroups of historical and/or concurrent sources of data.</p>
</div>
<div id="example-use-case" class="section level2">
<h2>Example use-case</h2>
<p>Consider the application described in Section 3.2 of [1], in which the risk of DLT is to be studied as a function of dose for two drugs, drug A and drug B. Historical information on the toxicity profiles of these two drugs is available from single agent trials <code>trial_A</code> and <code>trial_B</code>. The historical data for this example is available in an internal data set.</p>
<div class="sourceCode" id="cb1"><pre class="sourceCode r"><code class="sourceCode r"><a class="sourceLine" id="cb1-1" title="1"><span class="kw">kable</span>(hist_combo2)</a></code></pre></div>
<table>
<thead>
<tr class="header">
<th align="left">group_id</th>
<th align="right">drug_A</th>
<th align="right">drug_B</th>
<th align="right">num_patients</th>
<th align="right">num_toxicities</th>
<th align="right">cohort_time</th>
</tr>
</thead>
<tbody>
<tr class="odd">
<td align="left">trial_A</td>
<td align="right">3.0</td>
<td align="right">0.0</td>
<td align="right">3</td>
<td align="right">0</td>
<td align="right">0</td>
</tr>
<tr class="even">
<td align="left">trial_A</td>
<td align="right">4.5</td>
<td align="right">0.0</td>
<td align="right">3</td>
<td align="right">0</td>
<td align="right">0</td>
</tr>
<tr class="odd">
<td align="left">trial_A</td>
<td align="right">6.0</td>
<td align="right">0.0</td>
<td align="right">6</td>
<td align="right">0</td>
<td align="right">0</td>
</tr>
<tr class="even">
<td align="left">trial_A</td>
<td align="right">8.0</td>
<td align="right">0.0</td>
<td align="right">3</td>
<td align="right">2</td>
<td align="right">0</td>
</tr>
<tr class="odd">
<td align="left">trial_B</td>
<td align="right">0.0</td>
<td align="right">33.3</td>
<td align="right">3</td>
<td align="right">0</td>
<td align="right">0</td>
</tr>
<tr class="even">
<td align="left">trial_B</td>
<td align="right">0.0</td>
<td align="right">50.0</td>
<td align="right">3</td>
<td align="right">0</td>
<td align="right">0</td>
</tr>
<tr class="odd">
<td align="left">trial_B</td>
<td align="right">0.0</td>
<td align="right">100.0</td>
<td align="right">4</td>
<td align="right">0</td>
<td align="right">0</td>
</tr>
<tr class="even">
<td align="left">trial_B</td>
<td align="right">0.0</td>
<td align="right">200.0</td>
<td align="right">9</td>
<td align="right">0</td>
<td align="right">0</td>
</tr>
<tr class="odd">
<td align="left">trial_B</td>
<td align="right">0.0</td>
<td align="right">400.0</td>
<td align="right">15</td>
<td align="right">0</td>
<td align="right">0</td>
</tr>
<tr class="even">
<td align="left">trial_B</td>
<td align="right">0.0</td>
<td align="right">800.0</td>
<td align="right">20</td>
<td align="right">2</td>
<td align="right">0</td>
</tr>
<tr class="odd">
<td align="left">trial_B</td>
<td align="right">0.0</td>
<td align="right">1120.0</td>
<td align="right">17</td>
<td align="right">4</td>
<td align="right">0</td>
</tr>
</tbody>
</table>
<p>The objective is to aid dosing and dose-escalation decisions in a future trial, <code>trial_AB</code>, in which the drugs will be combined. Additionally, another investigator-initiated trial <code>IIT</code> will study the same combination concurrently. Note that these as-yet-unobserved sources of data are included in the input data as unobserved factor levels. This mechanism allows us to specify a joint meta-analytic prior for all four sources of historical and concurrent data.</p>
<div class="sourceCode" id="cb2"><pre class="sourceCode r"><code class="sourceCode r"><a class="sourceLine" id="cb2-1" title="1"><span class="kw">levels</span>(hist_combo2<span class="op">$</span>group_id)</a></code></pre></div>
<pre><code>## [1] &quot;trial_A&quot;  &quot;trial_B&quot;  &quot;IIT&quot;      &quot;trial_AB&quot;</code></pre>
<div id="fitting-the-model" class="section level3">
<h3>Fitting the model</h3>
<p>To fit the hierarchical model described in [4], one makes a call to the function <code>blrm_exnex</code>, as below; although we slightly deviate from the model in [4] by allowing an EXchangeable/Non-EXchangeable prior for the drug components.</p>
<div class="sourceCode" id="cb4"><pre class="sourceCode r"><code class="sourceCode r"><a class="sourceLine" id="cb4-1" title="1"><span class="co">## Load involved packages</span></a>
<a class="sourceLine" id="cb4-2" title="2"><span class="kw">library</span>(RBesT)  <span class="co">## defines logit function</span></a>
<a class="sourceLine" id="cb4-3" title="3"><span class="kw">library</span>(dplyr)  <span class="co">## for mutate</span></a>
<a class="sourceLine" id="cb4-4" title="4"><span class="kw">library</span>(tidyr)  <span class="co">## defines expand_grid</span></a>
<a class="sourceLine" id="cb4-5" title="5"></a>
<a class="sourceLine" id="cb4-6" title="6"><span class="co">## Design parameters ---------------------</span></a>
<a class="sourceLine" id="cb4-7" title="7"></a>
<a class="sourceLine" id="cb4-8" title="8">dref &lt;-<span class="st"> </span><span class="kw">c</span>(<span class="dv">3</span>, <span class="dv">960</span>)</a>
<a class="sourceLine" id="cb4-9" title="9">num_comp &lt;-<span class="st"> </span><span class="dv">2</span> <span class="co"># two investigational drugs</span></a>
<a class="sourceLine" id="cb4-10" title="10">num_inter &lt;-<span class="st"> </span><span class="dv">1</span> <span class="co"># one drug-drug interaction needs to be modeled</span></a>
<a class="sourceLine" id="cb4-11" title="11">num_groups &lt;-<span class="st"> </span><span class="kw">nlevels</span>(hist_combo2<span class="op">$</span>group_id) <span class="co"># four groups of data</span></a>
<a class="sourceLine" id="cb4-12" title="12">num_strata &lt;-<span class="st"> </span><span class="dv">1</span> <span class="co"># no stratification needed</span></a>
<a class="sourceLine" id="cb4-13" title="13"></a>
<a class="sourceLine" id="cb4-14" title="14"><span class="co">## abbreviate labels (wait for prior_summary)</span></a>
<a class="sourceLine" id="cb4-15" title="15"><span class="kw">options</span>(<span class="dt">OncoBayes2.abbreviate.min=</span><span class="dv">8</span>)</a>
<a class="sourceLine" id="cb4-16" title="16"></a>
<a class="sourceLine" id="cb4-17" title="17"><span class="co">## disables abbreviations (default)</span></a>
<a class="sourceLine" id="cb4-18" title="18"><span class="co">#options(OncoBayes2.abbreviate.min=0)</span></a>
<a class="sourceLine" id="cb4-19" title="19"></a>
<a class="sourceLine" id="cb4-20" title="20"><span class="co">## STRONGLY RECOMMENDED =&gt; uses 4 cores</span></a>
<a class="sourceLine" id="cb4-21" title="21"><span class="kw">options</span>(<span class="dt">mc.cores=</span><span class="dv">4</span>)</a>
<a class="sourceLine" id="cb4-22" title="22"></a>
<a class="sourceLine" id="cb4-23" title="23"><span class="co">## Model fit -----------------------------</span></a>
<a class="sourceLine" id="cb4-24" title="24"></a>
<a class="sourceLine" id="cb4-25" title="25">blrmfit &lt;-<span class="st"> </span><span class="kw">blrm_exnex</span>(</a>
<a class="sourceLine" id="cb4-26" title="26">  <span class="kw">cbind</span>(num_toxicities, num_patients <span class="op">-</span><span class="st"> </span>num_toxicities) <span class="op">~</span></a>
<a class="sourceLine" id="cb4-27" title="27"><span class="st">    </span><span class="dv">1</span> <span class="op">+</span><span class="st"> </span><span class="kw">I</span>(<span class="kw">log</span>(drug_A <span class="op">/</span><span class="st"> </span>dref[<span class="dv">1</span>])) <span class="op">|</span></a>
<a class="sourceLine" id="cb4-28" title="28"><span class="st">    </span><span class="dv">1</span> <span class="op">+</span><span class="st"> </span><span class="kw">I</span>(<span class="kw">log</span>(drug_B <span class="op">/</span><span class="st"> </span>dref[<span class="dv">2</span>])) <span class="op">|</span></a>
<a class="sourceLine" id="cb4-29" title="29"><span class="st">    </span><span class="dv">0</span> <span class="op">+</span><span class="st"> </span><span class="kw">I</span>(drug_A<span class="op">/</span>dref[<span class="dv">1</span>] <span class="op">*</span><span class="st"> </span>drug_B<span class="op">/</span>dref[<span class="dv">2</span>]) <span class="op">|</span></a>
<a class="sourceLine" id="cb4-30" title="30"><span class="st">    </span>group_id,</a>
<a class="sourceLine" id="cb4-31" title="31">  <span class="dt">data =</span> hist_combo2,</a>
<a class="sourceLine" id="cb4-32" title="32">  <span class="dt">prior_EX_mu_mean_comp =</span> <span class="kw">matrix</span>(</a>
<a class="sourceLine" id="cb4-33" title="33">    <span class="kw">c</span>(<span class="kw">logit</span>(<span class="fl">0.1</span>), <span class="dv">0</span>, <span class="co"># hyper-mean of (intercept, log-slope) for drug A</span></a>
<a class="sourceLine" id="cb4-34" title="34">      <span class="kw">logit</span>(<span class="fl">0.1</span>), <span class="dv">0</span>), <span class="co"># hyper-mean of (intercept, log-slope) for drug B</span></a>
<a class="sourceLine" id="cb4-35" title="35">    <span class="dt">nrow =</span> num_comp,</a>
<a class="sourceLine" id="cb4-36" title="36">    <span class="dt">ncol =</span> <span class="dv">2</span>,</a>
<a class="sourceLine" id="cb4-37" title="37">    <span class="dt">byrow =</span> <span class="ot">TRUE</span></a>
<a class="sourceLine" id="cb4-38" title="38">  ),</a>
<a class="sourceLine" id="cb4-39" title="39">  <span class="dt">prior_EX_mu_sd_comp =</span> <span class="kw">matrix</span>(</a>
<a class="sourceLine" id="cb4-40" title="40">    <span class="kw">c</span>(<span class="fl">3.33</span>, <span class="dv">1</span>, <span class="co"># hyper-sd of mean mu for (intercept, log-slope) for drug B</span></a>
<a class="sourceLine" id="cb4-41" title="41">      <span class="fl">3.33</span>, <span class="dv">1</span>), <span class="co"># hyper-sd of mean mu for (intercept, log-slope) for drug B</span></a>
<a class="sourceLine" id="cb4-42" title="42">    <span class="dt">nrow =</span> num_comp,</a>
<a class="sourceLine" id="cb4-43" title="43">    <span class="dt">ncol =</span> <span class="dv">2</span>,</a>
<a class="sourceLine" id="cb4-44" title="44">    <span class="dt">byrow =</span> <span class="ot">TRUE</span></a>
<a class="sourceLine" id="cb4-45" title="45">  ),</a>
<a class="sourceLine" id="cb4-46" title="46">  <span class="dt">prior_EX_tau_mean_comp =</span> <span class="kw">matrix</span>(</a>
<a class="sourceLine" id="cb4-47" title="47">    <span class="kw">c</span>(<span class="kw">log</span>(<span class="fl">0.25</span>), <span class="kw">log</span>(<span class="fl">0.125</span>),</a>
<a class="sourceLine" id="cb4-48" title="48">      <span class="kw">log</span>(<span class="fl">0.25</span>), <span class="kw">log</span>(<span class="fl">0.125</span>)),</a>
<a class="sourceLine" id="cb4-49" title="49">    <span class="dt">nrow =</span> num_comp,</a>
<a class="sourceLine" id="cb4-50" title="50">    <span class="dt">ncol =</span> <span class="dv">2</span>,</a>
<a class="sourceLine" id="cb4-51" title="51">    <span class="dt">byrow =</span> <span class="ot">TRUE</span></a>
<a class="sourceLine" id="cb4-52" title="52">  ),</a>
<a class="sourceLine" id="cb4-53" title="53">  <span class="dt">prior_EX_tau_sd_comp =</span> <span class="kw">matrix</span>(</a>
<a class="sourceLine" id="cb4-54" title="54">    <span class="kw">c</span>(<span class="kw">log</span>(<span class="dv">4</span>) <span class="op">/</span><span class="st"> </span><span class="fl">1.96</span>, <span class="kw">log</span>(<span class="dv">4</span>) <span class="op">/</span><span class="st"> </span><span class="fl">1.96</span>,</a>
<a class="sourceLine" id="cb4-55" title="55">      <span class="kw">log</span>(<span class="dv">4</span>) <span class="op">/</span><span class="st"> </span><span class="fl">1.96</span>, <span class="kw">log</span>(<span class="dv">4</span>) <span class="op">/</span><span class="st"> </span><span class="fl">1.96</span>),</a>
<a class="sourceLine" id="cb4-56" title="56">    <span class="dt">nrow =</span> num_comp,</a>
<a class="sourceLine" id="cb4-57" title="57">    <span class="dt">ncol =</span> <span class="dv">2</span>,</a>
<a class="sourceLine" id="cb4-58" title="58">    <span class="dt">byrow =</span> <span class="ot">TRUE</span></a>
<a class="sourceLine" id="cb4-59" title="59">  ),</a>
<a class="sourceLine" id="cb4-60" title="60">  <span class="dt">prior_EX_mu_mean_inter =</span> <span class="dv">0</span>,</a>
<a class="sourceLine" id="cb4-61" title="61">  <span class="dt">prior_EX_mu_sd_inter =</span> <span class="fl">1.121</span>,</a>
<a class="sourceLine" id="cb4-62" title="62">  <span class="dt">prior_EX_tau_mean_inter =</span> <span class="kw">matrix</span>(<span class="kw">log</span>(<span class="fl">0.125</span>), <span class="dt">nrow =</span> num_inter, <span class="dt">ncol =</span> num_strata),</a>
<a class="sourceLine" id="cb4-63" title="63">  <span class="dt">prior_EX_tau_sd_inter =</span> <span class="kw">matrix</span>(<span class="kw">log</span>(<span class="dv">4</span>) <span class="op">/</span><span class="st"> </span><span class="fl">1.96</span>, <span class="dt">nrow =</span> num_inter, <span class="dt">ncol =</span> num_strata),</a>
<a class="sourceLine" id="cb4-64" title="64">  <span class="dt">prior_is_EXNEX_comp =</span> <span class="kw">rep</span>(<span class="ot">TRUE</span>, num_comp),</a>
<a class="sourceLine" id="cb4-65" title="65">  <span class="dt">prior_is_EXNEX_inter =</span> <span class="kw">rep</span>(<span class="ot">FALSE</span>, num_inter),</a>
<a class="sourceLine" id="cb4-66" title="66">  <span class="co">## historical data is 100% EX</span></a>
<a class="sourceLine" id="cb4-67" title="67">  <span class="co">## new data only 80% EX</span></a>
<a class="sourceLine" id="cb4-68" title="68">  <span class="dt">prior_EX_prob_comp =</span> <span class="kw">matrix</span>(<span class="kw">c</span>(<span class="fl">1.0</span>, <span class="fl">1.0</span>,</a>
<a class="sourceLine" id="cb4-69" title="69">                                <span class="fl">1.0</span>, <span class="fl">1.0</span>,</a>
<a class="sourceLine" id="cb4-70" title="70">                                <span class="fl">0.8</span>, <span class="fl">0.8</span>,</a>
<a class="sourceLine" id="cb4-71" title="71">                                <span class="fl">0.8</span>, <span class="fl">0.8</span>),</a>
<a class="sourceLine" id="cb4-72" title="72">                              <span class="dt">nrow =</span> num_groups,</a>
<a class="sourceLine" id="cb4-73" title="73">                              <span class="dt">ncol =</span> num_comp,</a>
<a class="sourceLine" id="cb4-74" title="74">                              <span class="dt">byrow=</span><span class="ot">TRUE</span>),</a>
<a class="sourceLine" id="cb4-75" title="75">  <span class="dt">prior_EX_prob_inter =</span> <span class="kw">matrix</span>(<span class="dv">1</span>, <span class="dt">nrow =</span> num_groups, <span class="dt">ncol =</span> num_inter),</a>
<a class="sourceLine" id="cb4-76" title="76">  <span class="dt">prior_tau_dist =</span> <span class="dv">1</span></a>
<a class="sourceLine" id="cb4-77" title="77">)</a></code></pre></div>
<p>The function <code>blrm_exnex</code> returns an object from which numerical and graphical posterior summaries can be extracted using OncoBayes2 functions. We recommend making use of the methods described below.</p>
</div>
<div id="summary-of-prior-specification" class="section level3">
<h3>Summary of prior specification</h3>
<p>The function <code>prior_summary</code> provides a facility for printing, in a readable format, a summary of the prior specification.</p>
<div class="sourceCode" id="cb5"><pre class="sourceCode r"><code class="sourceCode r"><a class="sourceLine" id="cb5-1" title="1"><span class="kw">prior_summary</span>(blrmfit) <span class="co"># not run here</span></a></code></pre></div>
</div>
<div id="summary-of-posterior" class="section level3">
<h3>Summary of posterior</h3>
<p>The main target of inference is generally the probability of DLT at a selection of possible doses. In order to obtain this inference, one needs to specify the covariate levels of interest (which need not be present in the observed data).</p>
<p>In this case, we are interested in predicitons for <code>trial_AB</code>, with the possible combination doses of drugs A and B below.</p>
<div class="sourceCode" id="cb6"><pre class="sourceCode r"><code class="sourceCode r"><a class="sourceLine" id="cb6-1" title="1">newdata &lt;-<span class="st"> </span><span class="kw">expand_grid</span>(</a>
<a class="sourceLine" id="cb6-2" title="2">  <span class="dt">group_id =</span> <span class="kw">c</span>(<span class="st">&quot;trial_AB&quot;</span>),</a>
<a class="sourceLine" id="cb6-3" title="3">  <span class="dt">drug_A =</span> <span class="kw">c</span>(<span class="dv">0</span>, <span class="dv">3</span>, <span class="fl">4.5</span>, <span class="dv">6</span>),</a>
<a class="sourceLine" id="cb6-4" title="4">  <span class="dt">drug_B =</span> <span class="kw">c</span>(<span class="dv">0</span>, <span class="dv">400</span>, <span class="dv">600</span>, <span class="dv">800</span>)</a>
<a class="sourceLine" id="cb6-5" title="5">)</a>
<a class="sourceLine" id="cb6-6" title="6">newdata<span class="op">$</span>group_id &lt;-<span class="st"> </span><span class="kw">factor</span>(newdata<span class="op">$</span>group_id, <span class="kw">levels</span>(hist_combo2<span class="op">$</span>group_id))</a></code></pre></div>
<p>Note it is important that the factor levels associated with <code>newdata$group_id</code> be consistent with the levels of the grouping factor used when calling <code>blrm_exnex</code>. In case you use <code>expand.grid</code>, then the <code>stringsAsFactors = FALSE</code> argument must be used to ensures that the variable will initially be treated as a character. We recommend using the <code>tidyr</code> command <code>expand_grid</code> which avoids casting strings to factors in an uncontrolled manner. The next line converts the <code>group_id</code> column to a factor with the correct set of four levels. Alternativley, we can create the <code>group_id</code> column directly as a <code>factor</code> column within <code>newdata</code>. The code below results in the same <code>newdata</code> in a more compact form.</p>
<div class="sourceCode" id="cb7"><pre class="sourceCode r"><code class="sourceCode r"><a class="sourceLine" id="cb7-1" title="1">newdata &lt;-<span class="st"> </span><span class="kw">expand_grid</span>(</a>
<a class="sourceLine" id="cb7-2" title="2">  <span class="dt">group_id =</span> <span class="kw">factor</span>(<span class="kw">c</span>(<span class="st">&quot;trial_AB&quot;</span>), <span class="kw">levels</span>(hist_combo2<span class="op">$</span>group_id)),</a>
<a class="sourceLine" id="cb7-3" title="3">  <span class="dt">drug_A =</span> <span class="kw">c</span>(<span class="dv">0</span>, <span class="dv">3</span>, <span class="fl">4.5</span>, <span class="dv">6</span>),</a>
<a class="sourceLine" id="cb7-4" title="4">  <span class="dt">drug_B =</span> <span class="kw">c</span>(<span class="dv">0</span>, <span class="dv">400</span>, <span class="dv">600</span>, <span class="dv">800</span>)</a>
<a class="sourceLine" id="cb7-5" title="5">)</a></code></pre></div>
<p>Posterior summary statistics for the DLT rates at these provisional doses can be extracted from the <code>blrmfit</code> object using the <code>summary</code> method.</p>
<div class="sourceCode" id="cb8"><pre class="sourceCode r"><code class="sourceCode r"><a class="sourceLine" id="cb8-1" title="1">summ_stats &lt;-<span class="st"> </span><span class="kw">summary</span>(blrmfit, </a>
<a class="sourceLine" id="cb8-2" title="2">                      <span class="dt">newdata =</span> newdata,</a>
<a class="sourceLine" id="cb8-3" title="3">                      <span class="dt">prob =</span> <span class="fl">0.95</span>,</a>
<a class="sourceLine" id="cb8-4" title="4">                      <span class="dt">interval_prob =</span> <span class="kw">c</span>(<span class="dv">0</span>, <span class="fl">0.16</span>, <span class="fl">0.33</span>, <span class="dv">1</span>))</a>
<a class="sourceLine" id="cb8-5" title="5"></a>
<a class="sourceLine" id="cb8-6" title="6"><span class="kw">kable</span>(<span class="kw">cbind</span>(newdata, summ_stats), <span class="dt">digits =</span> <span class="dv">3</span>)</a></code></pre></div>
<table>
<thead>
<tr class="header">
<th align="left">group_id</th>
<th align="right">drug_A</th>
<th align="right">drug_B</th>
<th align="right">mean</th>
<th align="right">sd</th>
<th align="right">2.5%</th>
<th align="right">50%</th>
<th align="right">97.5%</th>
<th align="right">(0,0.16]</th>
<th align="right">(0.16,0.33]</th>
<th align="right">(0.33,1]</th>
</tr>
</thead>
<tbody>
<tr class="odd">
<td align="left">trial_AB</td>
<td align="right">0.0</td>
<td align="right">0</td>
<td align="right">0.000</td>
<td align="right">0.000</td>
<td align="right">0.000</td>
<td align="right">0.000</td>
<td align="right">0.000</td>
<td align="right">1.000</td>
<td align="right">0.000</td>
<td align="right">0.000</td>
</tr>
<tr class="even">
<td align="left">trial_AB</td>
<td align="right">0.0</td>
<td align="right">400</td>
<td align="right">0.068</td>
<td align="right">0.154</td>
<td align="right">0.000</td>
<td align="right">0.021</td>
<td align="right">0.656</td>
<td align="right">0.920</td>
<td align="right">0.031</td>
<td align="right">0.050</td>
</tr>
<tr class="odd">
<td align="left">trial_AB</td>
<td align="right">0.0</td>
<td align="right">600</td>
<td align="right">0.098</td>
<td align="right">0.167</td>
<td align="right">0.001</td>
<td align="right">0.049</td>
<td align="right">0.758</td>
<td align="right">0.877</td>
<td align="right">0.062</td>
<td align="right">0.060</td>
</tr>
<tr class="even">
<td align="left">trial_AB</td>
<td align="right">0.0</td>
<td align="right">800</td>
<td align="right">0.140</td>
<td align="right">0.176</td>
<td align="right">0.001</td>
<td align="right">0.091</td>
<td align="right">0.830</td>
<td align="right">0.783</td>
<td align="right">0.140</td>
<td align="right">0.078</td>
</tr>
<tr class="odd">
<td align="left">trial_AB</td>
<td align="right">3.0</td>
<td align="right">0</td>
<td align="right">0.100</td>
<td align="right">0.183</td>
<td align="right">0.000</td>
<td align="right">0.036</td>
<td align="right">0.838</td>
<td align="right">0.848</td>
<td align="right">0.084</td>
<td align="right">0.068</td>
</tr>
<tr class="even">
<td align="left">trial_AB</td>
<td align="right">3.0</td>
<td align="right">400</td>
<td align="right">0.167</td>
<td align="right">0.226</td>
<td align="right">0.003</td>
<td align="right">0.079</td>
<td align="right">0.932</td>
<td align="right">0.715</td>
<td align="right">0.148</td>
<td align="right">0.137</td>
</tr>
<tr class="odd">
<td align="left">trial_AB</td>
<td align="right">3.0</td>
<td align="right">600</td>
<td align="right">0.202</td>
<td align="right">0.237</td>
<td align="right">0.007</td>
<td align="right">0.110</td>
<td align="right">0.947</td>
<td align="right">0.624</td>
<td align="right">0.192</td>
<td align="right">0.184</td>
</tr>
<tr class="even">
<td align="left">trial_AB</td>
<td align="right">3.0</td>
<td align="right">800</td>
<td align="right">0.250</td>
<td align="right">0.253</td>
<td align="right">0.010</td>
<td align="right">0.154</td>
<td align="right">0.960</td>
<td align="right">0.511</td>
<td align="right">0.225</td>
<td align="right">0.264</td>
</tr>
<tr class="odd">
<td align="left">trial_AB</td>
<td align="right">4.5</td>
<td align="right">0</td>
<td align="right">0.148</td>
<td align="right">0.204</td>
<td align="right">0.003</td>
<td align="right">0.076</td>
<td align="right">0.904</td>
<td align="right">0.740</td>
<td align="right">0.156</td>
<td align="right">0.104</td>
</tr>
<tr class="even">
<td align="left">trial_AB</td>
<td align="right">4.5</td>
<td align="right">400</td>
<td align="right">0.218</td>
<td align="right">0.245</td>
<td align="right">0.008</td>
<td align="right">0.122</td>
<td align="right">0.959</td>
<td align="right">0.588</td>
<td align="right">0.206</td>
<td align="right">0.206</td>
</tr>
<tr class="odd">
<td align="left">trial_AB</td>
<td align="right">4.5</td>
<td align="right">600</td>
<td align="right">0.259</td>
<td align="right">0.266</td>
<td align="right">0.008</td>
<td align="right">0.155</td>
<td align="right">0.974</td>
<td align="right">0.508</td>
<td align="right">0.212</td>
<td align="right">0.279</td>
</tr>
<tr class="even">
<td align="left">trial_AB</td>
<td align="right">4.5</td>
<td align="right">800</td>
<td align="right">0.311</td>
<td align="right">0.292</td>
<td align="right">0.007</td>
<td align="right">0.202</td>
<td align="right">0.983</td>
<td align="right">0.438</td>
<td align="right">0.198</td>
<td align="right">0.364</td>
</tr>
<tr class="odd">
<td align="left">trial_AB</td>
<td align="right">6.0</td>
<td align="right">0</td>
<td align="right">0.211</td>
<td align="right">0.225</td>
<td align="right">0.005</td>
<td align="right">0.139</td>
<td align="right">0.951</td>
<td align="right">0.557</td>
<td align="right">0.264</td>
<td align="right">0.178</td>
</tr>
<tr class="even">
<td align="left">trial_AB</td>
<td align="right">6.0</td>
<td align="right">400</td>
<td align="right">0.284</td>
<td align="right">0.271</td>
<td align="right">0.011</td>
<td align="right">0.187</td>
<td align="right">0.979</td>
<td align="right">0.455</td>
<td align="right">0.227</td>
<td align="right">0.318</td>
</tr>
<tr class="odd">
<td align="left">trial_AB</td>
<td align="right">6.0</td>
<td align="right">600</td>
<td align="right">0.328</td>
<td align="right">0.300</td>
<td align="right">0.007</td>
<td align="right">0.221</td>
<td align="right">0.988</td>
<td align="right">0.421</td>
<td align="right">0.191</td>
<td align="right">0.388</td>
</tr>
<tr class="even">
<td align="left">trial_AB</td>
<td align="right">6.0</td>
<td align="right">800</td>
<td align="right">0.375</td>
<td align="right">0.330</td>
<td align="right">0.005</td>
<td align="right">0.274</td>
<td align="right">0.994</td>
<td align="right">0.384</td>
<td align="right">0.161</td>
<td align="right">0.454</td>
</tr>
</tbody>
</table>
<p>Such summaries may be used to assess which combination doses have acceptable risk of toxicity. For example, according the escalation with overdose control (EWOC) design criteria [3], any doses for which the last column does not exceed 25% are eligible for enrollment.</p>
</div>
<div id="data-scenarios" class="section level3">
<h3>Data scenarios</h3>
<p>Before <code>trial_AB</code> is initiated, it may be of interest to test how this model responds in various scenarios for the initial combination cohort(s).</p>
<p>This can be done easily in OncoBayes2 by updating the initial model fit with additional rows of hypothetical data. In the code below, we explore 3 possible outcomes for an initial cohort enrolled at 3 mg Drug A + 400 mg Drug B, and review the model’s inference at adjacent doses. Note that the <code>update</code> method for accepts an <code>add_data</code> argument which appends the additional data to the existing data of the previous analysis.</p>
<div class="sourceCode" id="cb9"><pre class="sourceCode r"><code class="sourceCode r"><a class="sourceLine" id="cb9-1" title="1"><span class="co"># set up two scenarios at the starting dose level</span></a>
<a class="sourceLine" id="cb9-2" title="2"><span class="co"># store them as data frames in a named list</span></a>
<a class="sourceLine" id="cb9-3" title="3">scenarios &lt;-<span class="st"> </span><span class="kw">expand_grid</span>(</a>
<a class="sourceLine" id="cb9-4" title="4">  <span class="dt">group_id  =</span> <span class="kw">factor</span>(<span class="st">&quot;trial_AB&quot;</span>, <span class="kw">levels</span>(hist_combo2<span class="op">$</span>group_id)),</a>
<a class="sourceLine" id="cb9-5" title="5">  <span class="dt">drug_A =</span> <span class="dv">3</span>,</a>
<a class="sourceLine" id="cb9-6" title="6">  <span class="dt">drug_B =</span> <span class="dv">400</span>,</a>
<a class="sourceLine" id="cb9-7" title="7">  <span class="dt">num_patients      =</span> <span class="dv">3</span>,</a>
<a class="sourceLine" id="cb9-8" title="8">  <span class="dt">num_toxicities      =</span> <span class="dv">1</span><span class="op">:</span><span class="dv">2</span></a>
<a class="sourceLine" id="cb9-9" title="9">) <span class="op">%&gt;%</span><span class="st"> </span><span class="kw">split</span>(<span class="dv">1</span><span class="op">:</span><span class="dv">2</span>) <span class="op">%&gt;%</span><span class="st"> </span><span class="kw">setNames</span>(<span class="kw">paste</span>(<span class="dv">1</span><span class="op">:</span><span class="dv">2</span>, <span class="st">&quot;DLTs&quot;</span>))</a>
<a class="sourceLine" id="cb9-10" title="10"></a>
<a class="sourceLine" id="cb9-11" title="11">candidate_doses &lt;-<span class="st"> </span><span class="kw">expand_grid</span>(</a>
<a class="sourceLine" id="cb9-12" title="12">  <span class="dt">group_id =</span> <span class="kw">factor</span>(<span class="st">&quot;trial_AB&quot;</span>, <span class="kw">levels</span>(hist_combo2<span class="op">$</span>group_id)),</a>
<a class="sourceLine" id="cb9-13" title="13">  <span class="dt">drug_A =</span> <span class="kw">c</span>(<span class="dv">3</span>, <span class="fl">4.5</span>),</a>
<a class="sourceLine" id="cb9-14" title="14">  <span class="dt">drug_B =</span> <span class="dv">400</span></a>
<a class="sourceLine" id="cb9-15" title="15">)</a>
<a class="sourceLine" id="cb9-16" title="16"></a>
<a class="sourceLine" id="cb9-17" title="17">scenario_inference &lt;-<span class="st"> </span><span class="kw">lapply</span>(scenarios, <span class="cf">function</span>(scenario_newdata){</a>
<a class="sourceLine" id="cb9-18" title="18">  </a>
<a class="sourceLine" id="cb9-19" title="19">  <span class="co"># refit the model with each scenario&#39;s additional data</span></a>
<a class="sourceLine" id="cb9-20" title="20">  scenario_fit &lt;-<span class="st"> </span><span class="kw">update</span>(blrmfit, <span class="dt">add_data =</span> scenario_newdata)</a>
<a class="sourceLine" id="cb9-21" title="21">  </a>
<a class="sourceLine" id="cb9-22" title="22">  <span class="co"># summarize posterior at candidate doses</span></a>
<a class="sourceLine" id="cb9-23" title="23">  scenario_summ &lt;-<span class="st"> </span><span class="kw">summary</span>(scenario_fit,</a>
<a class="sourceLine" id="cb9-24" title="24">                           <span class="dt">newdata =</span> candidate_doses,</a>
<a class="sourceLine" id="cb9-25" title="25">                           <span class="dt">interval_prob =</span> <span class="kw">c</span>(<span class="dv">0</span>, <span class="fl">0.16</span>, <span class="fl">0.33</span>, <span class="dv">1</span>))</a>
<a class="sourceLine" id="cb9-26" title="26">  </a>
<a class="sourceLine" id="cb9-27" title="27">  <span class="kw">cbind</span>(candidate_doses, scenario_summ)</a>
<a class="sourceLine" id="cb9-28" title="28">  </a>
<a class="sourceLine" id="cb9-29" title="29">})</a></code></pre></div>
<table>
<caption>Model inference when 1 DLT is observed in first cohort</caption>
<thead>
<tr class="header">
<th align="left">group_id</th>
<th align="right">drug_A</th>
<th align="right">drug_B</th>
<th align="right">mean</th>
<th align="right">sd</th>
<th align="right">2.5%</th>
<th align="right">50%</th>
<th align="right">97.5%</th>
<th align="right">(0,0.16]</th>
<th align="right">(0.16,0.33]</th>
<th align="right">(0.33,1]</th>
</tr>
</thead>
<tbody>
<tr class="odd">
<td align="left">trial_AB</td>
<td align="right">3.0</td>
<td align="right">400</td>
<td align="right">0.199</td>
<td align="right">0.216</td>
<td align="right">0.011</td>
<td align="right">0.126</td>
<td align="right">0.93</td>
<td align="right">0.598</td>
<td align="right">0.248</td>
<td align="right">0.154</td>
</tr>
<tr class="even">
<td align="left">trial_AB</td>
<td align="right">4.5</td>
<td align="right">400</td>
<td align="right">0.263</td>
<td align="right">0.235</td>
<td align="right">0.017</td>
<td align="right">0.190</td>
<td align="right">0.96</td>
<td align="right">0.426</td>
<td align="right">0.304</td>
<td align="right">0.270</td>
</tr>
</tbody>
</table>
<table>
<caption>Model inference when 2 DLTs are observed in first cohort</caption>
<thead>
<tr class="header">
<th align="left">group_id</th>
<th align="right">drug_A</th>
<th align="right">drug_B</th>
<th align="right">mean</th>
<th align="right">sd</th>
<th align="right">2.5%</th>
<th align="right">50%</th>
<th align="right">97.5%</th>
<th align="right">(0,0.16]</th>
<th align="right">(0.16,0.33]</th>
<th align="right">(0.33,1]</th>
</tr>
</thead>
<tbody>
<tr class="odd">
<td align="left">trial_AB</td>
<td align="right">3.0</td>
<td align="right">400</td>
<td align="right">0.290</td>
<td align="right">0.274</td>
<td align="right">0.006</td>
<td align="right">0.199</td>
<td align="right">0.981</td>
<td align="right">0.423</td>
<td align="right">0.264</td>
<td align="right">0.313</td>
</tr>
<tr class="even">
<td align="left">trial_AB</td>
<td align="right">4.5</td>
<td align="right">400</td>
<td align="right">0.361</td>
<td align="right">0.290</td>
<td align="right">0.010</td>
<td align="right">0.286</td>
<td align="right">0.989</td>
<td align="right">0.317</td>
<td align="right">0.236</td>
<td align="right">0.447</td>
</tr>
</tbody>
</table>
</div>
</div>
<div id="continuation-of-example" class="section level2">
<h2>Continuation of example</h2>
<p>In the example of [1], at the time of completion of <code>trial_AB</code>, the complete historical and concurrent data are as follows.</p>
<div class="sourceCode" id="cb10"><pre class="sourceCode r"><code class="sourceCode r"><a class="sourceLine" id="cb10-1" title="1"><span class="kw">kable</span>(codata_combo2)</a></code></pre></div>
<table>
<thead>
<tr class="header">
<th align="left">group_id</th>
<th align="right">drug_A</th>
<th align="right">drug_B</th>
<th align="right">num_patients</th>
<th align="right">num_toxicities</th>
<th align="right">cohort_time</th>
</tr>
</thead>
<tbody>
<tr class="odd">
<td align="left">trial_A</td>
<td align="right">3.0</td>
<td align="right">0.0</td>
<td align="right">3</td>
<td align="right">0</td>
<td align="right">0</td>
</tr>
<tr class="even">
<td align="left">trial_A</td>
<td align="right">4.5</td>
<td align="right">0.0</td>
<td align="right">3</td>
<td align="right">0</td>
<td align="right">0</td>
</tr>
<tr class="odd">
<td align="left">trial_A</td>
<td align="right">6.0</td>
<td align="right">0.0</td>
<td align="right">6</td>
<td align="right">0</td>
<td align="right">0</td>
</tr>
<tr class="even">
<td align="left">trial_A</td>
<td align="right">8.0</td>
<td align="right">0.0</td>
<td align="right">3</td>
<td align="right">2</td>
<td align="right">0</td>
</tr>
<tr class="odd">
<td align="left">trial_A</td>
<td align="right">4.5</td>
<td align="right">0.0</td>
<td align="right">3</td>
<td align="right">0</td>
<td align="right">1</td>
</tr>
<tr class="even">
<td align="left">trial_A</td>
<td align="right">6.0</td>
<td align="right">0.0</td>
<td align="right">5</td>
<td align="right">0</td>
<td align="right">1</td>
</tr>
<tr class="odd">
<td align="left">trial_B</td>
<td align="right">0.0</td>
<td align="right">33.3</td>
<td align="right">3</td>
<td align="right">0</td>
<td align="right">0</td>
</tr>
<tr class="even">
<td align="left">trial_B</td>
<td align="right">0.0</td>
<td align="right">50.0</td>
<td align="right">3</td>
<td align="right">0</td>
<td align="right">0</td>
</tr>
<tr class="odd">
<td align="left">trial_B</td>
<td align="right">0.0</td>
<td align="right">100.0</td>
<td align="right">4</td>
<td align="right">0</td>
<td align="right">0</td>
</tr>
<tr class="even">
<td align="left">trial_B</td>
<td align="right">0.0</td>
<td align="right">200.0</td>
<td align="right">9</td>
<td align="right">0</td>
<td align="right">0</td>
</tr>
<tr class="odd">
<td align="left">trial_B</td>
<td align="right">0.0</td>
<td align="right">400.0</td>
<td align="right">15</td>
<td align="right">0</td>
<td align="right">0</td>
</tr>
<tr class="even">
<td align="left">trial_B</td>
<td align="right">0.0</td>
<td align="right">800.0</td>
<td align="right">20</td>
<td align="right">2</td>
<td align="right">0</td>
</tr>
<tr class="odd">
<td align="left">trial_B</td>
<td align="right">0.0</td>
<td align="right">1120.0</td>
<td align="right">17</td>
<td align="right">4</td>
<td align="right">0</td>
</tr>
<tr class="even">
<td align="left">IIT</td>
<td align="right">3.0</td>
<td align="right">400.0</td>
<td align="right">3</td>
<td align="right">0</td>
<td align="right">1</td>
</tr>
<tr class="odd">
<td align="left">IIT</td>
<td align="right">3.0</td>
<td align="right">800.0</td>
<td align="right">7</td>
<td align="right">5</td>
<td align="right">1</td>
</tr>
<tr class="even">
<td align="left">IIT</td>
<td align="right">4.5</td>
<td align="right">400.0</td>
<td align="right">3</td>
<td align="right">0</td>
<td align="right">1</td>
</tr>
<tr class="odd">
<td align="left">IIT</td>
<td align="right">6.0</td>
<td align="right">400.0</td>
<td align="right">6</td>
<td align="right">0</td>
<td align="right">1</td>
</tr>
<tr class="even">
<td align="left">IIT</td>
<td align="right">6.0</td>
<td align="right">600.0</td>
<td align="right">3</td>
<td align="right">2</td>
<td align="right">1</td>
</tr>
<tr class="odd">
<td align="left">trial_AB</td>
<td align="right">3.0</td>
<td align="right">400.0</td>
<td align="right">3</td>
<td align="right">0</td>
<td align="right">1</td>
</tr>
<tr class="even">
<td align="left">trial_AB</td>
<td align="right">3.0</td>
<td align="right">800.0</td>
<td align="right">6</td>
<td align="right">2</td>
<td align="right">1</td>
</tr>
<tr class="odd">
<td align="left">trial_AB</td>
<td align="right">4.5</td>
<td align="right">600.0</td>
<td align="right">10</td>
<td align="right">2</td>
<td align="right">1</td>
</tr>
<tr class="even">
<td align="left">trial_AB</td>
<td align="right">6.0</td>
<td align="right">400.0</td>
<td align="right">10</td>
<td align="right">3</td>
<td align="right">1</td>
</tr>
</tbody>
</table>
<p>Numerous toxicities were observed in the concurrent <code>IIT</code> study. Through the MAC framework, these data can influence the model summaries for <code>trial_AB</code>. Note that we use the <code>update</code> function differently than before, since we specify the entire data-set now we use the <code>data</code> argument.</p>
<div class="sourceCode" id="cb11"><pre class="sourceCode r"><code class="sourceCode r"><a class="sourceLine" id="cb11-1" title="1">final_fit &lt;-<span class="st"> </span><span class="kw">update</span>(blrmfit, <span class="dt">data =</span> codata_combo2)</a>
<a class="sourceLine" id="cb11-2" title="2"></a>
<a class="sourceLine" id="cb11-3" title="3">summ &lt;-<span class="st"> </span><span class="kw">summary</span>(final_fit, newdata, <span class="dt">prob =</span> <span class="kw">c</span>(<span class="fl">0.5</span>, <span class="fl">0.95</span>), <span class="dt">interval_prob =</span> <span class="kw">c</span>(<span class="dv">0</span>,<span class="fl">0.33</span>,<span class="dv">1</span>))</a>
<a class="sourceLine" id="cb11-4" title="4"></a>
<a class="sourceLine" id="cb11-5" title="5">final_summ_stats &lt;-<span class="st"> </span><span class="kw">cbind</span>(newdata, summ) <span class="op">%&gt;%</span></a>
<a class="sourceLine" id="cb11-6" title="6"><span class="st">    </span><span class="kw">mutate</span>(<span class="dt">EWOC=</span><span class="dv">1</span><span class="op">*</span><span class="st">`</span><span class="dt">(0.33,1]</span><span class="st">`</span><span class="op">&lt;=</span><span class="fl">0.25</span>)</a></code></pre></div>
<div class="sourceCode" id="cb12"><pre class="sourceCode r"><code class="sourceCode r"><a class="sourceLine" id="cb12-1" title="1"><span class="kw">ggplot</span>(final_summ_stats,</a>
<a class="sourceLine" id="cb12-2" title="2">       <span class="kw">aes</span>(<span class="dt">x=</span><span class="kw">factor</span>(drug_B), <span class="dt">colour=</span>EWOC)) <span class="op">+</span></a>
<a class="sourceLine" id="cb12-3" title="3"><span class="st">    </span><span class="kw">facet_wrap</span>(<span class="op">~</span>drug_A, <span class="dt">labeller=</span>label_both) <span class="op">+</span></a>
<a class="sourceLine" id="cb12-4" title="4"><span class="st">    </span><span class="kw">scale_y_continuous</span>(<span class="dt">breaks=</span><span class="kw">c</span>(<span class="dv">0</span>, <span class="fl">0.16</span>, <span class="fl">0.33</span>, <span class="fl">0.4</span>, <span class="fl">0.6</span>, <span class="fl">0.8</span>, <span class="fl">1.0</span>)) <span class="op">+</span></a>
<a class="sourceLine" id="cb12-5" title="5"><span class="st">    </span><span class="kw">coord_cartesian</span>(<span class="dt">ylim=</span><span class="kw">c</span>(<span class="dv">0</span>,<span class="fl">0.8</span>)) <span class="op">+</span></a>
<a class="sourceLine" id="cb12-6" title="6"><span class="st">    </span><span class="kw">geom_hline</span>(<span class="dt">yintercept =</span> <span class="kw">c</span>(<span class="fl">0.16</span>, <span class="fl">0.33</span>),</a>
<a class="sourceLine" id="cb12-7" title="7">               <span class="dt">linetype =</span> <span class="st">&quot;dotted&quot;</span>) <span class="op">+</span></a>
<a class="sourceLine" id="cb12-8" title="8"><span class="st">    </span><span class="kw">geom_pointrange</span>(<span class="kw">aes</span>(<span class="dt">y=</span><span class="st">`</span><span class="dt">50%</span><span class="st">`</span>, <span class="dt">ymin=</span><span class="st">`</span><span class="dt">2.5%</span><span class="st">`</span>, <span class="dt">ymax=</span><span class="st">`</span><span class="dt">97.5%</span><span class="st">`</span>)) <span class="op">+</span></a>
<a class="sourceLine" id="cb12-9" title="9"><span class="st">    </span><span class="kw">geom_linerange</span>(<span class="kw">aes</span>(<span class="dt">ymin=</span><span class="st">`</span><span class="dt">25%</span><span class="st">`</span>, <span class="dt">ymax=</span><span class="st">`</span><span class="dt">75%</span><span class="st">`</span>), <span class="dt">size=</span><span class="fl">1.5</span>) <span class="op">+</span></a>
<a class="sourceLine" id="cb12-10" title="10"><span class="st">    </span><span class="kw">ggtitle</span>(<span class="st">&quot;DLT Probability&quot;</span>, <span class="st">&quot;Shown is the median (dot), 50% CrI (thick line) and 95% CrI (thin line)&quot;</span>) <span class="op">+</span></a>
<a class="sourceLine" id="cb12-11" title="11"><span class="st">    </span><span class="kw">ylab</span>(<span class="ot">NULL</span>) <span class="op">+</span><span class="st"> </span></a>
<a class="sourceLine" id="cb12-12" title="12"><span class="st">    </span><span class="kw">xlab</span>(<span class="st">&quot;Dose Drug B [mg]&quot;</span>)</a></code></pre></div>
<p><img src="data:image/png;base64,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" /><!-- --></p>
</div>
<div id="references" class="section level2">
<h2>References</h2>
<p>[1] Neuenschwander, B., Roychoudhury, S., &amp; Schmidli, H. (2016). On the use of co-data in clinical trials. Statistics in Biopharmaceutical Research, 8(3), 345-354.</p>
<p>[2] Neuenschwander, B., Wandel, S., Roychoudhury, S., &amp; Bailey, S. (2016). Robust exchangeability designs for early phase clinical trials with multiple strata. Pharmaceutical statistics, 15(2), 123-134.</p>
<p>[3] Neuenschwander, B., Branson, M., &amp; Gsponer, T. (2008). Critical aspects of the Bayesian approach to phase I cancer trials. Statistics in medicine, 27(13), 2420-2439.</p>
<p>[4] Neuenschwander, B., Matano, A., Tang, Z., Roychoudhury, S., Wandel, S. Bailey, Stuart. (2014). A Bayesian Industry Approach to Phase I Combination Trials in Oncology. In Statistical methods in drug combination studies (Vol. 69). CRC Press.</p>
</div>
<div id="session-info" class="section level2">
<h2>Session Info</h2>
<div class="sourceCode" id="cb13"><pre class="sourceCode r"><code class="sourceCode r"><a class="sourceLine" id="cb13-1" title="1"><span class="kw">sessionInfo</span>()</a></code></pre></div>
<pre><code>## R version 3.6.1 (2019-07-05)
## Platform: x86_64-pc-linux-gnu (64-bit)
## Running under: Ubuntu 16.04.6 LTS
## 
## Matrix products: default
## BLAS:   /usr/lib/libblas/libblas.so.3.6.0
## LAPACK: /usr/lib/lapack/liblapack.so.3.6.0
## 
## locale:
## [1] C
## 
## attached base packages:
## [1] stats     graphics  grDevices utils     datasets  methods   base     
## 
## other attached packages:
## [1] tidyr_1.0.0      dplyr_0.8.3      RBesT_1.4-0      ggplot2_3.2.1   
## [5] knitr_1.25       OncoBayes2_0.5-8 Rcpp_1.0.2      
## 
## loaded via a namespace (and not attached):
##  [1] rstan_2.19.2       tidyselect_0.2.5   xfun_0.10         
##  [4] purrr_0.3.3        colorspace_1.4-1   vctrs_0.2.0       
##  [7] htmltools_0.4.0    stats4_3.6.1       loo_2.1.0         
## [10] yaml_2.2.0         rlang_0.4.0        pkgbuild_1.0.6    
## [13] pillar_1.4.2       withr_2.1.2        glue_1.3.1        
## [16] matrixStats_0.55.0 lifecycle_0.1.0    plyr_1.8.4        
## [19] stringr_1.4.0      munsell_0.5.0      gtable_0.3.0      
## [22] mvtnorm_1.0-11     codetools_0.2-16   evaluate_0.14     
## [25] inline_0.3.15      callr_3.3.2        ps_1.3.0          
## [28] parallel_3.6.1     bayesplot_1.7.0    highr_0.8         
## [31] rstantools_2.0.0   scales_1.0.0       backports_1.1.5   
## [34] checkmate_1.9.4    StanHeaders_2.19.0 abind_1.4-5       
## [37] gridExtra_2.3      digest_0.6.21      stringi_1.4.3     
## [40] processx_3.4.1     grid_3.6.1         cli_1.1.0         
## [43] tools_3.6.1        magrittr_1.5       lazyeval_0.2.2    
## [46] tibble_2.1.3       Formula_1.2-3      crayon_1.3.4      
## [49] pkgconfig_2.0.3    zeallot_0.1.0      ellipsis_0.3.0    
## [52] prettyunits_1.0.2  ggridges_0.5.1     assertthat_0.2.1  
## [55] rmarkdown_1.16     R6_2.4.0           compiler_3.6.1</code></pre>
</div>



<!-- code folding -->


<!-- dynamically load mathjax for compatibility with self-contained -->
<script>
  (function () {
    var script = document.createElement("script");
    script.type = "text/javascript";
    script.src  = "https://mathjax.rstudio.com/latest/MathJax.js?config=TeX-AMS-MML_HTMLorMML";
    document.getElementsByTagName("head")[0].appendChild(script);
  })();
</script>

</body>
</html>
